- Home
- CLAR vs PLX Comparison
CLAR vs PLX Comparison
Compare CLAR & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLAR
- PLX
- Stock Information
- Founded
- CLAR 1957
- PLX 1993
- Country
- CLAR United States
- PLX Israel
- Employees
- CLAR N/A
- PLX N/A
- Industry
- CLAR Recreational Games/Products/Toys
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLAR Consumer Discretionary
- PLX Health Care
- Exchange
- CLAR Nasdaq
- PLX Nasdaq
- Market Cap
- CLAR 173.0M
- PLX 160.2M
- IPO Year
- CLAR N/A
- PLX 1998
- Fundamental
- Price
- CLAR $4.75
- PLX $2.39
- Analyst Decision
- CLAR Strong Buy
- PLX Strong Buy
- Analyst Count
- CLAR 3
- PLX 1
- Target Price
- CLAR $6.33
- PLX $15.00
- AVG Volume (30 Days)
- CLAR 117.3K
- PLX 646.5K
- Earning Date
- CLAR 03-06-2025
- PLX 03-13-2025
- Dividend Yield
- CLAR 2.10%
- PLX N/A
- EPS Growth
- CLAR N/A
- PLX N/A
- EPS
- CLAR 0.13
- PLX N/A
- Revenue
- CLAR $269,413,000.00
- PLX $45,667,000.00
- Revenue This Year
- CLAR N/A
- PLX N/A
- Revenue Next Year
- CLAR $9.30
- PLX $63.84
- P/E Ratio
- CLAR $37.61
- PLX N/A
- Revenue Growth
- CLAR 48.98
- PLX N/A
- 52 Week Low
- CLAR $3.89
- PLX $0.82
- 52 Week High
- CLAR $7.55
- PLX $2.76
- Technical
- Relative Strength Index (RSI)
- CLAR 49.18
- PLX 48.43
- Support Level
- CLAR $4.80
- PLX $2.43
- Resistance Level
- CLAR $4.94
- PLX $2.73
- Average True Range (ATR)
- CLAR 0.17
- PLX 0.13
- MACD
- CLAR -0.01
- PLX -0.04
- Stochastic Oscillator
- CLAR 46.81
- PLX 13.95
About CLAR Clarus Corporation
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.